| Lactate receptor sites link neurotransmission, neurovascular coupling, and brain energy metabolism KH Lauritzen, C Morland, M Puchades, S Holm-Hansen, EM Hagelin, ... Cerebral cortex 24 (10), 2784-2795, 2014 | 336 | 2014 |
| Subcellular movement and expression of HSP27, αB-crystallin, and HSP70 after two bouts of eccentric exercise in humans G Paulsen, F Lauritzen, ML Bayer, JM Kalhovde, I Ugelstad, SG Owe, ... Journal of applied physiology 107 (2), 570-582, 2009 | 177 | 2009 |
| Gross ultrastructural changes and necrotic fiber segments in elbow flexor muscles after maximal voluntary eccentric action in humans F Lauritzen, G Paulsen, T Raastad, LH Bergersen, SG Owe Journal of Applied Physiology 107 (6), 1923-1934, 2009 | 170 | 2009 |
| Loss of perivascular Kir4. 1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy K Heuser, T Eid, F Lauritzen, AE Thoren, GF Vindedal, E Taubøll, ... Journal of Neuropathology & Experimental Neurology 71 (9), 814-825, 2012 | 120 | 2012 |
| Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy EL Perez, F Lauritzen, Y Wang, TSW Lee, D Kang, HP Zaveri, ... Neurobiology of Disease 47 (3), 331-337, 2012 | 70 | 2012 |
| Doping prevention through anti-doping education and practical strength training: The Hercules program D Sagoe, G Holden, ENK Rise, T Torgersen, G Paulsen, T Krosshaug, ... Performance Enhancement & Health 5 (1), 24-30, 2016 | 54 | 2016 |
| Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus F Lauritzen, NC de Lanerolle, TSW Lee, DD Spencer, JH Kim, ... Neurobiology of disease 41 (2), 577-584, 2011 | 54 | 2011 |
| Inflammatory markers CD11b, CD16, CD66b, CD68, myeloperoxidase and neutrophil elastase in eccentric exercised human skeletal muscles G Paulsen, I Egner, T Raastad, F Reinholt, S Owe, F Lauritzen, ... Histochemistry and cell biology 139, 691-715, 2013 | 51 | 2013 |
| Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy F Lauritzen, EL Perez, ER Melillo, JM Roh, HP Zaveri, TSW Lee, Y Wang, ... Neurobiology of disease 45 (1), 165-176, 2012 | 50 | 2012 |
| Monocarboxylate transporters in temporal lobe epilepsy: roles of lactate and ketogenic diet F Lauritzen, T Eid, LH Bergersen Brain Structure and Function 220, 1-12, 2015 | 46 | 2015 |
| Dietary supplements as a major cause of anti-doping rule violations F Lauritzen Frontiers in sports and active living 4, 101, 2022 | 30 | 2022 |
| Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus F Lauritzen, K Heuser, NC de Lanerolle, TSW Lee, DD Spencer, JH Kim, ... Glia 60 (7), 1172-1181, 2012 | 30 | 2012 |
| Doping substances in dietary supplements C Helle, AK Sommer, PV Syversen, F Lauritzen Tidsskrift for Den norske legeforening, 2019 | 27 | 2019 |
| Gene expression of glutamate metabolizing enzymes in the hippocampal formation in human temporal lobe epilepsy T Eid, TSW Lee, Y Wang, E Peréz, J Drummond, F Lauritzen, ... Epilepsia 54 (2), 228-238, 2013 | 26 | 2013 |
| Trends in dietary supplement use among athletes selected for doping controls F Lauritzen, A Gjelstad Frontiers in Nutrition 10, 1143187, 2023 | 16 | 2023 |
| Dopingmidler i kosttilskudd C Helle, AK Sommer, PV Syversen, F Lauritzen Tidsskrift for Den norske legeforening, 2019 | 13 | 2019 |
| Ten years of collecting hematological athlete biological passport samples—perspectives from a National Anti-doping Organization LV Bækken, G Holden, A Gjelstad, F Lauritzen Frontiers in Sports and Active Living 4, 954479, 2022 | 7 | 2022 |
| Lactate receptor locations link neurotransmission, neurovascular coupling, and brain energy metabolism LH Bergersen, KH Lauritzen, F Lauritzen, M Puchades, A Gjedde JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 32, S183-S183, 2012 | 7 | 2012 |
| Intelligence‐based doping control planning improves testing effectiveness: Perspectives from a national anti‐doping organisation F Lauritzen, G Holden Drug Testing and Analysis 15 (5), 506-515, 2023 | 6 | 2023 |
| Use of pharmaceuticals amongst athletes tested by Anti-Doping Norway in a five-year period A Gjelstad, TM Herlofsen, AL Bjerke, F Lauritzen, I Björnsdottir Frontiers in Sports and Active Living 5, 1260806, 2023 | 3 | 2023 |
